Meaghan Webster
Communications Manager
Atomic Pulse
Continued monitoring of international efforts to enhance
biosecurity and prepare for future global health emergencies is crucial to
maintaining the momentum generated by the Global Health Security Agenda (GHSA),
Dr. Elizabeth Cameron told a seminar
hosted by Georgetown University’s Center for Global Health Science and Security
last week.
Launched in February 2014, the GHSA
is a partnership that convenes countries, international organizations and
non-governmental organizations (NGOs) to help prevent infectious disease
threats and elevate global health security as both national and global priorities.
Cameron,
senior director for global biological policy and programs at the Nuclear Threat
Initiative, and former senior director for global health security and
biodefense on the White House National Security Council staff, explained that
the Unites States’ active leadership and upfront financial commitments to GHSA
priorities were crucial to securing commitments from dozens of other countries
– a partnership that would not have been possible without coordination at the
domestic level.
“Convening heads-of-state, calling for tangible commitments and incentivizing accountability to commitments are the primary ways the U.S. can remain a leader in this space,” Cameron said.
While GHSA addresses a range of global health priorities, Cameron argued that global leaders must maintain a particular focus on biosecurity preparedness, including capacity to stop outbreaks at the source and prevent potential bioterrorism incidents.
“Whether it occurs by a quirk of nature or at the hand of a terrorist, epidemiologists say a fast-moving airborne pathogen could kill more than 30 million people in less than a year. And they say there is a reasonable probability the world will experience such an outbreak in the next 10 to 15 years.” – Bill Gates
Cameron highlighted the important role academic and NGO
communities can play in advancing global health security – by vigorously
tracking countries’ commitments to biosecurity and emergency preparedness.
The
Joint External Evaluation (JEE), a public-private partnership dedicated to
measuring concrete progress toward biosecurity goals, is one such method,
Cameron noted. Other initiatives include the development of a Global
Health Security Index, a project NTI is pursuing with the Johns Hopkins
Center for Health Security to provide a public benchmarking of global
biosecurity conditions—modelling many of the lessons learned from NTI’s
first-of-its-kind Nuclear Security Index.
Read more about the Global Health Security Index here,
and find more on NTI’s biosecurity work here.
Sign up for our newsletter to get the latest on nuclear and biological threats.
AI biodesign tools offer many beneficial uses, from engineered crops to vaccine development, but tools that can engineer biological agents could also be misused to cause harm.
Gaps in healthcare infrastructure and biosecurity capabilities among Global South countries make these regions particularly vulnerable to biological threats, both natural and man-made.
NTI | bio convened two technical working groups this fall to address critical challenges at the intersection of AI and the life sciences, bringing together more than 50 international experts from major AI companies, academic institutions, and biosecurity organizations.